Independent intelligence for the laboratory world

,

DNAnexus Expands AI Tools for Governed Multiomics Research

DNAnexus has introduced new AI-focused capabilities for ingesting, organizing, analyzing, and governing multiomics data in precision-health research.

Computational biologist reviewing governed genomics and multiomics cohort visualizations

DNAnexus has expanded its platform with AI-focused capabilities intended to help research teams work with growing collections of genomic, transcriptomic, proteomic, and related clinical data.

Multiomics programs combine several data types to study disease, identify biomarkers, or stratify patient populations. The scientific opportunity is significant, but the operational burden is equally large. Teams must ingest diverse files, harmonize metadata, define cohorts, control access, and preserve the provenance of analyses that may run across cloud infrastructure.

Self-service analysis on governed data

DNAnexus says the release improves multiomic data ingestion and cohorting while giving scientists more self-service access to approved data. The company also announced an AutoML Assistant that is intended to help users prepare and evaluate machine-learning work without building every step from scratch.

Bringing AI tools closer to governed data can reduce the need to copy sensitive information into separate environments. It can also let platform administrators apply common controls for identity, permissions, compute, and audit history. The scientific benefit depends on whether users can understand the transformations applied to each data set and reproduce the path from a cohort definition to a model result.

Model governance joins data governance

Organizations evaluating the new tools should look beyond access control. They will need records of training data, feature selection, software versions, evaluation metrics, and intended use. For clinical or translational work, teams should test for cohort bias and data leakage before treating a promising model as evidence.

DNAnexus has an established role in secure biomedical data infrastructure, which gives the company a foundation for integrated AI workflows. The announcement does not remove the need for experienced data scientists or domain review. It does suggest that cloud research platforms are increasingly expected to govern the model lifecycle alongside the data lifecycle, turning reproducibility and permissioning into core AI product features.

View the original press release.

Industries: , ,

Join the Discussion

Share your experience or ask a question about this article. Please keep comments relevant and respectful.

Leave a Reply

Your email address will not be published. Required fields are marked *